Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/handle/10553/145654
Title: Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study
Authors: González Lleó, Ana María 
Brito Casillas, Yeray 
Martin-Santana, Virginia
Gil Quintana, Yaiza María 
Tugores Céster, Antonio 
Scicali, Roberto
Riaño Ruiz, Marta 
Hernández Baraza, Luisa 
Jiménez Monzón,Roberto 
Girona, Josefa
Di Giacomo Barbagallo, Francesco
Masana, Luis
Boronat Cortés, Mauro 
Wägner, Anna Maria Claudia 
Sanchez Hernández, Rosa María 
UNESCO Clasification: 32 Ciencias médicas
320502 Endocrinología
320501 Cardiología
3205 Medicina interna
Keywords: Insulin Sensitivity
Canary-Islands
Gran-Canaria
Cardiovascular Risk
Statin Therapy, et al
Issue Date: 2025
Journal: Cardiovascular Diabetology 
Abstract: Background Heterozygous familial hypercholesterolemia (HeFH) is typically associated with a lower prevalence of type 2 diabetes mellitus (T2DM). However, individuals carrying the p.[Tyr400_Phe402del]LDLR mutation, which is prevalent in Gran Canaria, exhibit an unexpectedly high prevalence of T2DM. This study aimed to investigate whether the p.[Tyr400_Phe402del] LDLR mutation co-segregates with T2DM and other glucose metabolism abnormalities.MethodsA total of 226 individuals were recruited, with 196 included in the final analysis. This included 90 HeFH patients from Gran Canaria (HeFH-GC) carrying the p.[Tyr400_Phe402del]LDLR mutation, 76 first-degree relatives (non-HeFH), and 30 HeFH patients from Italy (HeFH-It) with other LDLR mutations. Clinical, anthropometric, biochemical, and hematological parameters, including insulin resistance and sensitivity, were assessed via oral glucose tolerance tests (OGTT), and indices such as HOMA-IR, HOMA-beta, QUICKI, and the triglyceride-glucose ratio were measured.ResultsAmong HeFH-GC participants, 20% had T2DM, similar to 18.4% in the non-HeFH group (p = NS). HOMA-beta was significantly greater in HeFH-GC patients (86.2 vs. 68.4; p = 0.046). Normoglycemic HeFH-GC individuals had elevated HOMA-IR [2.0 (1.3-2.9) vs. 1.3 (1.0-1.9); p = 0.008]. Compared with HeFH-It patients, HeFH-GC individuals had higher fasting glucose levels (99 vs. 92.5 mg/dL; p = 0.004) and lower 120-min post-OGTT glucose levels (115 vs. 136.5 mg/dL; p = 0.001). Lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference were associated with T2DM.ConclusionsHeFH patients from Gran Canaria exhibit a high prevalence of T2DM. The p.[Tyr400_Phe402del]LDLR mutation does not co-segregate with T2DM, but normoglycemic HeFH-GC individuals have greater insulin resistance. Additionally, lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference are factors associated with the prevalence of T2DM.
URI: https://accedacris.ulpgc.es/handle/10553/145654
DOI: 10.1186/s12933-025-02857-8
Source: Cardiovascular Diabetology [EISSN 1475-2840], v. 24 (1), (Diciembre 2025).
Appears in Collections:Artículos
Show full item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.